Skip to main content
Clinical Trials/KCT0008903
KCT0008903RecruitingUnknown

Comparative clinical research between Osstem KS SOI and Straumann Roxolid SLActive

Osstem Implant0 sites22 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Recruiting
Sponsor
Enrollment
22

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20(Year) to o Limit (—)
Sex
All

Inclusion Criteria

  • •1. Patients who signed the clinical trial consent form
  • •2. Adult patients over 20 years of age
  • •3. Patients with sufficient bone height and appropriate bone width
  • •4. Patients whose extraction site has been completely healed (patients with a healing period of at least 2 months after extraction)
  • •5. Patients with 2 or more missing teeth in the upper or lower molar region

Exclusion Criteria

  • •1. Patients whose predispositions that could intervene in clinical research results, such as periodontal disease and caries in the oral cavity, have not been completely removed before implant placement
  • •2. Patients with Bruxism or Clenching Habit
  • •3. Pregnant women and patients with uncontrolled systemic disease
  • •4. Persons taking drugs for bone diseases such as osteoporosis
  • •5. Patients with a history of radiation therapy to the face and neck
  • •6. Mental illness or suspected mental illness
  • •7. People who are hypersensitive to implant materials
  • •8. Patients with a history of receiving chemotherapy such as chemotherapy for the past 1 year
  • •9. Persons with a history of recent myocardial infarction or uncontrolled hemorrhagic disease
  • •10. Others who are ethically or who may affect the results of a clinical trial and are inappropriate to participate in a clinical trial as determined by the clinical trial director

Investigators

Sponsor
Osstem Implant

Similar Trials

Evaluation of clinical safety and... | Clinical Trial